Search results
Results from the WOW.Com Content Network
Drug disposal programs have been cited as an effective tool in the fight against opioid abuse by medical studies and the White House. Now Google is lending a hand by pinpointing 3,500 of these ...
Glipizide, sold under the brand name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes. [1] [2] It is used together with a diabetic diet and exercise. [1] [2] It is not indicated for use by itself in type 1 diabetes. [1] [2] It is taken by mouth.
The take-back events are part of a mission to create safe medication disposal sites, prevent drug diversion or transfer of the prescribed drug for illicit use, and provide education for the public. [29] In April 2021, the program reported the collection of 420 short tons (380,000 kg) of drugs at 5,060 sites around the country. [28]
Depending on the sources and ingredients, there are various ways in which the public can dispose of pharmaceutical and personal care products in acceptable ways. The most environmentally safe disposal method is to take advantage of community drug take-back programs that collect drugs at a central location for proper disposal.
World-leading organizations such as WHO and UNICEF recommended several appropriate and safe drug disposal options and drug use prevention. With large supplies of drugs, drug pollution and negative environmental impact of pharmaceuticals and personal care products becomes a concern. Also, drug recycling might be a possibility.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
U.S. Food and Drug Administration (FDA). 18 May 2016. "FDA Drug Safety Communication: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate". U.S. Food and Drug Administration (FDA). 9 May 2017.
The Ohio Automated Rx Reporting System (OARRS) is Ohio's state Prescription Monitoring Program (PMP) and is controlled by the Ohio State Board of Pharmacy. [1] The law permitting the Board of Pharmacy to create the PMP was signed on March 18, 2005, and became effective January 1, 2006. The OARRS program began operation on October 2, 2006.